paclitaxel has been researched along with Systemic Inflammatory Response Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, TH; Choi, D; Han, SH; Jang, Y; Jeon, DW; Kang, WC; Kim, BK; Kim, JS; Ko, YG; Moon, CI; Oh, SJ; Shin, EK; Yang, JY | 1 |
Garcia, JG; Kolosova, IA; Mirzapoiazova, T; Moreno, L; Sammani, S; Verin, AD | 1 |
1 trial(s) available for paclitaxel and Systemic Inflammatory Response Syndrome
Article | Year |
---|---|
Comparison of inflammatory markers and angiographic outcomes after implantation of sirolimus and paclitaxel-eluting stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Paclitaxel; Prognosis; Prospective Studies; Sirolimus; Systemic Inflammatory Response Syndrome; Treatment Outcome; Tubulin Modulators; Ultrasonography | 2009 |
1 other study(ies) available for paclitaxel and Systemic Inflammatory Response Syndrome
Article | Year |
---|---|
Suppression of endotoxin-induced inflammation by taxol.
Topics: Animals; Bronchoalveolar Lavage Fluid; Capillary Leak Syndrome; Endotoxemia; Extravasation of Diagnostic and Therapeutic Materials; Leukocyte Count; Lipopolysaccharides; Lung; Mice; Mice, Inbred C57BL; Paclitaxel; Peritonitis; Peroxidase; Pulmonary Edema; Respiratory Distress Syndrome; Systemic Inflammatory Response Syndrome; Tubulin Modulators | 2007 |